About Sherlock Biosciences
Sherlock Biosciences news and updates
Sherlock Biosciences received financing of $80M in funding on Mar 8th 22'.
Sherlock Biosciences announced today that it raised $80 million in a Series B financing round to support its next-generation diagnostics.
Jan 1, 2022 | massdevice.comSherlock Biosciences hires Paul Meister as board of directors
“The pandemic undoubtedly shone a light on long-existing challenges in its healthcare system, from inaccessibility to inconvenience and concerns around privacy,” Novalis partner Paul Meister, who will join Sherlock’s board of directors, said in a statement.
Jan 1, 2022 | fiercebiotech.comNovalis LifeSciences LLC invests into Sherlock Biosciences in $80M
Sherlock Biosciences has raised $80m in a Series B financing led by Novalis LifeSciences to develop new at-home diagnostic tests.
Jan 1, 2022 | medicaldevice-network.comIllumina Ventures invests into Sherlock Biosciences in $80M
Sherlock Biosciences has raised $80 million in a Series B financing led by Novalis LifeSciences and new investors Illumina Ventures, Albany Capital and Catalio Capital Management.
Jan 1, 2022 | crisprmedicinenews.comSherlock Biosciences hired Karen Davies as Chief Development Officer on Apr 7th 22'.
Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point-of-need, today announced that industry veteran Karen Davies has been appointed to its executive team as Chief Development Officer.
Jan 1, 2022 | prnewswire.comSherlock Biosciences received award Emergency Use Authorization on May 1st 20'.
For instance, In May 2020, Sherlock Biosciences announced that it had received Emergency Use Authorization from the United States Food and Drug Administration (FDA) for its Sherlock CRISPR SARS-CoV-2 kit which is used for the detection of the virus that causes COVID-19.
Jan 1, 2022 | globenewswire.comSherlock Biosciences hires Julie Garlikov as chief commercial officer
Sherlock Biosciences has appointed Julie Garlikov as chief commercial officer, a new position at the molecular diagnostics firm.
Jan 1, 2022 | genomeweb.comBill & Melinda Gates Foundation invested into Sherlock Biosciences on Nov 29th 22'.
Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point of need, today announced that it has received additional funding from the Bill & Melinda Gates Foundation to advance its rapid, instrument-free molecular diagnostic testing platform.
Nov 29, 2022 | prnewswire.com